Exalenz Bioscience
Exalenz Bioscience commercializes the BreathID System which extracts vital information for diagnostics.
Launch date
Employees
Market cap
-
Enterprise valuation
€45m (Public information from Feb 2020)
Rosh Haayin Center District (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
| N/A | N/A | IPO | |
* | $49.0m Valuation: $49.0m | Acquisition | |
| Total Funding | - | ||
Related Content
Recent News about Exalenz Bioscience
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.